A self-triggered radioligand therapy agent for fluorescence imaging of the treatment response in prostate cancer.
Xu H, Wang Y, Zhang J, Duan X, Zhang T, Cai X, Ha H, Byun Y, Fan Y, Yang Z, Wang Y, Liu Z, Yang X.
Xu H, et al. Among authors: zhang t, zhang j.
Eur J Nucl Med Mol Imaging. 2022 Jul;49(8):2693-2704. doi: 10.1007/s00259-022-05743-7. Epub 2022 Mar 2.
Eur J Nucl Med Mol Imaging. 2022.
PMID: 35235005